Anticancer Therapies – News and Features

A new method combines microscopy with single-cell RNA analysis to make the technique more accessible and scalable, giving researchers an advantage in the numbers game of single-cell analysis.

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.

A University of Rochester research team found that four common species of bats possess superpowers, allowing them to live up to 35 years – equivalent to approximately 180 human years – without developing cancer.

This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients.

Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts on many types of cancer cells (Eva1) and successfully eliminated tumors in lab mice.

A new blood test that uncovers hidden changes inside cancer cells could help doctors find the best treatments for children and young people with cancer.

A new Phase 2 trial suggests that using an electric field device placed on the scalp, along with immunotherapy and chemotherapy may help patients with glioblastoma live longer – particularly those with large, inoperable tumors.

Researchers at Charité - Universitätsmedizin Berlin look for new cancer diagnostic procedures. The result is an AI model that makes use of the specific characteristics in the genetic material of tumors.

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based approaches, highlighting their expanding clinical use, underlying mechanisms and the challenges that lie ahead.